CREEWOLFSPEED, INC.


$ 25.54 $ 0.35 (1.39 %)    

Friday, 17-May-2024 15:59:55 EDT
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 25.53
$ 25.25
$ 0.00 x 0
$ 0.00 x 0
$ 24.96 - $ 26.14
$ 20.63 - $ 70.42
2,027,392
na
na
$ 1.53
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 analyst-ratings-for-cree
Analyst Ratings For Cree
09/27/2021 16:52:05

Within the last quarter, Cree (NASDAQ:CREE) has observed the following analyst ratings:

 deutsche-bank-maintains-hold-on-cree-lowers-price-target-to-90

Deutsche Bank analyst Sidney Ho maintains Cree (NASDAQ:CREE) with a Hold and lowers the price target from $100 to $90.

 10-information-technology-stocks-showing-unusual-options-activity-in-todays-session

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances ...

 expert-ratings-for-cree
Expert Ratings For Cree
09/17/2021 16:06:48

Within the last quarter, Cree (NASDAQ:CREE) has observed the following analyst ratings:

 bofa-downgrades-synopsys-cirrus-logic-cree-names-top-q4-semi-picks

Bank of America remains bullish on semiconductor stocks heading into the fourth quarter, but the firm issued three semi stock d...

 benzingas-top-ratings-upgrades-downgrades-for-september-17-2021

Upgrades

 b-of-a-securities-downgrades-cree-to-underperform-announces-93-price-target

B of A Securities analyst Vivek Arya downgrades Cree (NASDAQ:CREE) from Neutral to Underperform and announces $93 price target.

 12-information-technology-stocks-moving-in-wednesdays-after-market-session

Gainers

 46-biggest-movers-from-yesterday
46 Biggest Movers From Yesterday
08/19/2021 09:11:19

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% ...

 34-stocks-moving-in-wednesdays-mid-day-session

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 139% to $8.18 after surging over 15% on Tuesday.

 piper-sandler-maintains-neutral-on-cree-lowers-price-target-to-80

Piper Sandler analyst Harsh Kumar maintains Cree (NASDAQ:CREE) with a Neutral and lowers the price target from $110 to $80.

 canaccord-genuity-maintains-buy-on-cree-raises-price-target-to-136

Canaccord Genuity analyst Jed Dorsheimer maintains Cree (NASDAQ:CREE) with a Buy and raises the price target from $132 to $136.

 22-stocks-moving-in-wednesdays-pre-market-session

Gainers

 wells-fargo-maintains-equal-weight-on-cree-lowers-price-target-to-85

Wells Fargo analyst Gary Mobley maintains Cree (NASDAQ:CREE) with a Equal-Weight and lowers the price target from $115 to $85.

 a-peek-into-the-markets-us-stock-futures-mostly-lower-ahead-of-fed-minutes

Pre-open movers

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION